Insilico's AI-designed drug proves effective in treating lung disease
Longevity Technology - 20-Sep-2024Phase 2a trial results show positive outcomes among pulmonary fibrosis patients
Alex Zhavoronkov
CEO of InSilico Medicine & Deep Longevity. CSO of Biogerontology Research Foundation
Dr. Zhavoronkov holds two bachelor degrees from Queen’s University, a master’s in Biotechnology from Johns Hopkins University, and a PhD in Physics and Mathematics from Moscow State University.
As at Sept-20: 313 Publications, 4,053 Citations
Prior to founding Insilico Medicine, he worked in senior roles at ATI Technologies (acquired by AMD in 2006), NeuroG Neuroinformatics, the Biogerontology Research Foundation and YLabs.AI and established AgeNet.net competitions and diversity.AI initiative.
Author of "The Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy", Palgrave Macmillan, NY, 2013 - available in English, Japanese, Chinese, and Polish.
Visit website: http://www.agelessbook.com/the-author-details/
See also: 
Insilico Medicine
- Biotechnology company that uses artificial intelligence to develop new drugs and for aging research
Details last updated 04-Jul-2019
Alex Zhavoronkov is also referenced in the following:
4th International Conference on Aging and Disease (2023 ICAD)
27-Oct-2023 to 30-Oct-2023
Conference on Aging and Disease organized by International Society on Aging and Disease (ISOAD)
ARDD 2020 - 7th Aging Research and Drug Discovery Meeting
01-Sep-2020 to 04-Aug-2020
Latest progress in the molecular, cellular and organismal basis of aging
ARDD 2021 - 8th Aging Research and Drug Discovery Meeting
31-Aug-2021 to 03-Sep-2021
Online event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen chaired by Morten Scheibye-Knudsen, Daniela Bakula and Alex Zhavoronkov, and with many speakers.
ARDD 2022 - 9th Aging Research and Drug Discovery Meeting
29-Aug-2022 to 02-Sep-2022
Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen
ARDD 2023 - 10th Aging Research & Drug Discovery Meeting
28-Aug-2023 to 01-Sep-2023
Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen
Artificial Intelligence-based Biomarkers of Ageing
04-Feb-2021
NUS Healthy Longevity webinar with Alex Zhavoronkov - CEO of Insilico Medicine
Biological Clocks and How You Can Use Them
26-Mar-2021
AMA with Sergey Young, Alex Zhavoronkov and Sourav Sinha
BSRA Annual Scientific Meeting 2023
06-Sep-2023 to 08-Sep-2023
A compelling lineup of speakers from all areas of the biology of ageing
Healthy Masters International Conference
05-Nov-2022 to 06-Nov-2022
Healthy Masters conference about living longer and healthier life
Healthy Masters International Conference 2023
11-Nov-2023 to 12-Nov-2023
Healthy Masters conference about living longer and healthier life
Innovations in Consumer Longevity Data: A Global Perspective
19-Nov-2021
Ageing Research at King's (ARK) Longevity Week 2021 Event (FREE)
Launching Mind Age on SenoClock Platform
20-Apr-2023
1 hour virtual event organized by Deep Longevity with Alex Zhavoronkov and Deepankar Nayak
Live Longer with AI
By Tina Woods - How artificial intelligence is helping us extend our healthspan and live better too
Longevity Investors Conference 2022
28-Sep-2022 to 30-Sep-2022
Conference gathering longevity experts and investors at one place hosted by Marc P. Bernegger and Dr. Tobias Reichmuth
Longevity Investors Conference 2023
27-Sep-2023 to 29-Sep-2023
Conference gathering longevity experts and investors at one place hosted by Marc P. Bernegger, Dr. Tobias Reichmuth and Daniel Koetser
Longevity Medicine Workshop
30-Aug-2021
Workshop is part of ARDD 2021 conference that brings health care providers involved in longevity, organized by Cassandra Coburn and Evelyne Bischof. (FREE)
Longevity Summit Dublin 2023
17-Aug-2023 to 20-Aug-2023
Club discount available - click here
Event gathering Global Longevity and Rejuvenation community in Dublin with many longevity movement superstars as speakers
Longevity therapeutics: AI discovery of dual-purpose aging & disease drugs
24-Oct-2022
Online event about harnessing the power of AI to improve the discovery process for drugs by OSAL with Alex Zhavoronkov (FREE)
Metabesity 2021
11-Oct-2021 to 14-Oct-2021
The Kitalys institute virtual conference targeting key questions that will impact the future of aging and extending healthspan
Targeting Metabesity 2022
10-Oct-2022 to 13-Oct-2022
The Kitalys Institute virtual conference about going beyond treating individual diseases to extending healthy lifespan
Alex Zhavoronkov Creations
The Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy
The Ageless Generation by Alex Zhavoronkov is an engaging work that causes us to rethink our ideas of age and ability in the modern world
Alex Zhavoronkov News
Insilico Medicine showcases 10 years of AI success in drug discovery
GEN - 01-Aug-2024AI could cut preclinical drug development time by half, but rigorous trials are crucial
Viral video sparks debate on head transplants for immortality
MIT Technology Review - 23-May-2024Experts discuss on the ethics and feasibility of body transplants in the near future
SRW and Insilico partner to develop AI-powered nutraceuticals
Longevity Technology - 08-Nov-2023Using AI to screen natural compounds and create novel longevity products
Lifespan.io reports back from Aging Research and Drug Discovery Meeting (ARDD 2023)
Lifespan.io (LEAF) - 26-Sep-2023Key points from Arkadi Mazin's summary of 5 days of talks by geroscientists and biotech leaders
BBC reports on two different uses of AI in pharmaceutical healthcare
BBC - 17-Apr-2023Genetika+ tests drugs against a patient's own cells; Insilico Medicine is slashing the time taken for drug discovery
Insilico Medicine series D funding to grow its pipeline and create an AI-driven robotic drug discovery laboratory
Longevity Technology - 06-Jun-2022Big data combined with laboratory automation - the pace of drug discovery is about to take off!
Deep Longevity's epigenetic aging clock, DeepMAge, retrained to use saliva samples
Longevity Technology - 02-Aug-2021With an accuracy of 4.7 years it is much more convenient for home testing
Insilico raises $255M to advance human trials and AI drug discovery platform
Longevity Technology - 22-Jun-2021New collab with Teva Pharmaceuticals to identify drug targets for various diseases
First-ever AI designed drug candidate for pulmonary fibrosis
Longevity Technology - 24-Feb-2021Insilico's novel drug target is prepping for IND studies, expecting to start clinical studies by early 2022
Super summary of 3rd Annual Longevity Therapeutics Summit
Lifespan.io (LEAF) - 16-Feb-2021More and more companies making greater and greater progress - 2021 could be an exciting year
AI based aging clock predicts psychological age
Longevity Technology - 16-Dec-2020Deep longevity's psychological clock might help you feel younger and live longer
Pharma company teams with AI to develop anti aging solutions
Longevity Technology - 15-Oct-2020Taisho and Insilico collabs to identify novel targets for senolytic drugs
Alex Zhavoronkov explains why AI can help in peer reviewing drug development research
Nature Biotechnology - 14-Sep-2020An automated sense-check of publications sounds like a good idea
New app helps identify biological age and methods to slow it down
Fortune - 17-Aug-2020Apps such as Young. ai will play a key role in helping understand and reversing aging processes
AI reduces drug discovery from years to days - and that's just the start
Singularity Hub - 23-Jul-2020Insilico Medicine is slashing the cost of drug development
Deep Longevity investors bet on growing need for aging and longevity biomarkers
FierceBiotech - 15-Jul-2020Biological clocks are a moving target so they'll need other researchers to corroborate their analysis
Should WHO use a new framework for the diagnosis and treatment of age-related diseases?
Lifespan.io (LEAF) - 08-May-2020LEAF summarises and exchange of thoughts between leading aging researchers
Proposed strategy to protect elderly from gerolavic infections like COVID-19
Forbes - 31-Mar-2020To benefit long term global health and longevity, and enhance economic recovery
Nanalyze looks at Insilico Medicine's AlphaGo moment in pharma
Nanalyze - 09-Oct-2019From lab to clinic in 2 years instead of 10 would have a huge impact on health
Display all news
Articles written by Alex Zhavoronkov
Insilico Medicine showcases 10 years of AI success in drug discovery
GEN - 01-Aug-2024AI could cut preclinical drug development time by half, but rigorous trials are crucial
Artificial intelligence can revolutionise longevity medicine
Nature Aging - 14-Jan-2021Collaboration among stakeholders can transform public health into public health longevity
